Using data science to improve outcomes for persons with opioid use disorder. Issue 1 (1st December 2022)

• Record Type: Journal Article
• Authors: Hayes, Corey J.; Cucciare, Michael A.; Martin, Bradley C.; Hudson, Teresa J.; Bush, Keith; Lo-Ciganic, Weihsuan; Yu, Hong; Charron, Elizabeth; Gordon, Adam J.
• Is Part Of: Substance abuse. Volume 43:Issue 1(2022)
• Page Start: 956
• Page End: 963
• Publication Date: 2022-12-01
• Subjects: Opioid-related disorders -- machine learning -- big data; Substance abuse -- Periodicals; Medical education -- Periodicals; Education, Medical -- periodicals; Substance Abuse -- periodicals; 362.29
• DOI: 10.1080/08897077.2022.2060446
• Languages: English
• ISSNs: 0889-7077

Abstract

Abstract: Medication treatment for opioid use disorder (MOUD) is an effective evidence-based therapy for decreasing opioid-related adverse outcomes. Effective strategies for retaining persons on MOUD, an essential step to improving outcomes, are needed as roughly half of all persons initiating MOUD discontinue within a year. Data science may be valuable and promising for improving MOUD retention by using "big data" (e.g., electronic health record data, claims data mobile/sensor data, social media data) and specific machine learning techniques (e.g., predictive modeling, natural language processing, reinforcement learning) to individualize patient care. Maximizing the utility of data science to improve MOUD retention requires a three-pronged approach: (1) increasing funding for data science research for OUD, (2) integrating data from multiple sources including treatment for OUD and general medical care as well as data not specific to medical care (e.g., mobile, sensor, and social media data), and (3) applying multiple data science approaches with integrated big data to provide insights and optimize advances in the OUD and overall addiction fields.